Evidence map›Paper›PMID 32991275›Full record

ArticleGlobal public health2021

Depression and delayed tuberculosis treatment initiation among newly diagnosed patients in Botswana.

Keneilwe Molebatsi, Qiao Wang, Mbatshi Dima, Ari Ho-Foster, Chawangwa Modongo, Nicola Zetola, Sanghyuk S Shin

Open access · greenAbstract read
In one paragraph

Article in Global public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.1field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Keneilwe MolebatsiDepartment of Psychiatry, University of Botswana, Gaborone, Botswana.ORCID 0000-0003-4741-3278
Qiao WangSue & Bill Gross School of Nursing, University of California Irvine, Irvine, CA, USA.
Mbatshi DimaBotswana-UPenn Partnership, Gaborone, Botswana.
Ari Ho-FosterOffice of Research and Graduate Studies, Faculty of Medicine, University of Botswana, Gaborone, Botswana.ORCID 0000-0001-9817-8090
Chawangwa ModongoBotswana-UPenn Partnership, Gaborone, Botswana.
Nicola ZetolaPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Sanghyuk S ShinSue & Bill Gross School of Nursing, University of California Irvine, Irvine, CA, USA.ORCID 0000-0001-9982-4373
Botswana Open University · BWUniversity of Botswana · BWUniversity of California, Irvine · USUniversity of Pennsylvania · US

Funding

The Effect of Mixed-strain Mycobacterium tuberculosis Infections on TB Treatment Outcomes in Botswana: A Retrospective Cohort Study.K01AI118559 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SHIN, SANGHYUK SAM · 2015 to 2019
$670k
NIAID NIH HHS K01 AI118559
6 · The paper itself

Abstract

Comorbidity of tuberculosis (TB) and depression may lead to delayed TB treatment initiation. A cross-sectional study was conducted between January and December 2019 to examine the association between depression and delayed TB treatment initiation among newly diagnosed TB patients in Botswana. We used the Patient Health Questionnaire-9 and the ZUNG self-rating anxiety scale to assess depressive and anxiety symptoms, respectively. Delayed TB treatment was defined as experiencing common TB symptoms for more than 2 months before treatment initiation. We used Poisson regression models with robust variance to assess the association between covariates and delayed treatment initiation. Majority of the enrolled 180 study participants were males (n =116, 64.4%). Overall, 99 (55%) were co-infected with HIV; depression and anxiety symptoms were reported by 47.2% and 38.5% of the participants respectively. The prevalence of delayed TB treatment was 42.6% and 18.8% among participants who indicated symptoms of depression and among participants without depression respectively. After adjusting for age, HIV status, gender and anxiety symptoms, depression was still associated with delayed TB treatment (adjusted prevalence ratio [aPR] = 2.09; 95% CI = 1.23-3.57). Integrating management of depressive symptoms during TB treatment may help in improving overall TB treatment outcomes.

Indexed as

HIV InfectionsTuberculosisBotswanaCross-Sectional StudiesDepressionHumansMalePrevalenceAnxietycommon mental disordersHIVmental illnessTB/HIV comorbidity

Identifiers

PMID32991275
PMCPMC8005506
OpenAlexW3089464599

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.